{"data":{"id":"us-ks/k.s.a.-65-6b03","jurisdiction":"us-ks","citation":"K.S.A. 65-6b03","heading":"Same; when prescribed or administered.","body":"A physician may prescribe or administer amygdalin (laetrile) as an adjunct to recognized, customary or accepted modes of therapy or by itself in the treatment of any malignancy, disease, illness or physical condition of a patient who has signed the written informed request substantially as set forth in K.S.A. 65-6b05.","path":["Chapter 65.—PUBLIC HEALTH","Article 6b.—AMYGDALIN (LAETRILE)"],"source_url":"https://www.ksrevisor.gov/statutes/chapters/ch65/065_006b_0003.html","current_through":"2025 legislative session","vintage":"","retrieved_at":"2026-10-15T06:25:06Z","sha256":"70ba50bd543372fdef9b7dd2dda1e44b39a1e683bb2caa2b62acdb60af41428b","source_id":"us-ks","stale":false,"prev":"us-ks/k.s.a.-65-6b02","next":"us-ks/k.s.a.-65-6b04"},"notice":"GroundRules: Original legal text. Not legal advice."}